menu ☰
menu ˟

The utility of tumor markers and neutrophil lymphocyte ratio in patients with an intraoperative diagnosis of mucinous borderline ovarian tumor

24 Nov 2015

To evaluate the utility of tumor markers and complete blood count to increase the diagnostic accuracy to detect malignant cases that are intraoperatively reported as mucinous borderline ovarian tumors (BOT).

Click here to view the full article which appeared in European Journal of Obstetrics & Gynecology and Reproductive Biology